DaVita Inc. (0I7E.L)
0I7E.L Stock Price Chart
Explore DaVita Inc. interactive price chart. Choose custom timeframes to analyze 0I7E.L price movements and trends.
0I7E.L Company Profile
Discover essential business fundamentals and corporate details for DaVita Inc. (0I7E.L) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Equipment & Services
IPO Date
29 Jan 2018
Employees
76.00K
Website
https://www.davita.comCEO
Javier J. Rodriguez
Description
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services to 16,000 patients in risk-based integrated care arrangements and 7,000 patients in other integrated care arrangements; vascular access services; clinical research programs; physician services; and comprehensive kidney care services. As of December 31, 2021, it provided dialysis and administrative services in the United States through a network of 2,815 outpatient dialysis centers serving approximately 203,100 patients; and operated 339 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 39,900 patients. Further, the company provides acute inpatient dialysis services in approximately 850 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
0I7E.L Financial Timeline
Browse a chronological timeline of DaVita Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 11 May 2026
Upcoming earnings on 11 Feb 2026
Upcoming earnings on 27 Oct 2025
Upcoming earnings on 4 Aug 2025
Revenue estimate is $3.36B.
Earnings released on 12 May 2025
EPS came in at $2.00 surpassing the estimated $1.95 by +2.56%, while revenue for the quarter reached $3.22B, missing expectations by -3.96%.
Earnings released on 13 Feb 2025
EPS came in at $3.09 surpassing the estimated $2.13 by +45.07%, while revenue for the quarter reached $3.29B, beating expectations by +0.87%.
Earnings released on 30 Oct 2024
EPS came in at $2.50 falling short of the estimated $2.72 by -8.09%, while revenue for the quarter reached $3.26B, beating expectations by +0.50%.
Earnings released on 7 Aug 2024
EPS came in at $2.50 falling short of the estimated $2.59 by -3.47%, while revenue for the quarter reached $3.19B, beating expectations by +1.10%.
Earnings released on 3 May 2024
EPS came in at $2.65 surpassing the estimated $1.95 by +35.90%, while revenue for the quarter reached $3.07B, beating expectations by +1.41%.
Earnings released on 4 Mar 2024
EPS came in at $1.62 falling short of the estimated $1.63 by -0.61%, while revenue for the quarter reached $3.15B, beating expectations by +4.57%.
Earnings released on 8 Nov 2023
EPS came in at $2.62 surpassing the estimated $2.01 by +30.35%, while revenue for the quarter reached $3.12B, beating expectations by +3.39%.
Earnings released on 4 Aug 2023
EPS came in at $1.91 surpassing the estimated $1.71 by +11.70%, while revenue for the quarter reached $3.00B, beating expectations by +1.65%.
Earnings released on 9 May 2023
EPS came in at $1.25 surpassing the estimated $1.18 by +5.93%, while revenue for the quarter reached $2.87B, beating expectations by +1.22%.
Earnings released on 23 Feb 2023
EPS came in at $0.60 falling short of the estimated $0.93 by -36.23%, while revenue for the quarter reached $2.92B, missing expectations by -0.49%.
Earnings released on 30 Sept 2022
EPS came in at $1.13 falling short of the estimated $1.77 by -36.16%, while revenue for the quarter reached $2.95B, missing expectations by -0.95%.
Earnings released on 30 Jun 2022
EPS came in at $2.30 surpassing the estimated $2.09 by +10.05%, while revenue for the quarter reached $2.93B, missing expectations by -0.27%.
Earnings released on 31 Mar 2022
EPS came in at $1.61 falling short of the estimated $1.87 by -13.90%, while revenue for the quarter reached $2.82B, missing expectations by -2.45%.
Dividend declared on 15 Mar 2022
A dividend of $0.29 per share was announced, adjusted to $0.29.
Earnings released on 9 Feb 2022
EPS came in at $1.79 falling short of the estimated $1.80 by -0.56%, while revenue for the quarter reached $2.94B, beating expectations by +1.02%.
Earnings released on 28 Oct 2021
EPS came in at $2.64, while revenue for the quarter reached $2.92B.
Earnings released on 30 Sept 2021
EPS came in at $2.36, while revenue for the quarter reached $2.94B.
Earnings released on 31 Mar 2021
EPS came in at $2.09, while revenue for the quarter reached $2.82B.
Earnings released on 31 Dec 2020
EPS came in at $1.67, while revenue for the quarter reached $2.91B.
Earnings released on 30 Sept 2020
EPS came in at $1.28, while revenue for the quarter reached $2.92B.
0I7E.L Stock Performance
Access detailed 0I7E.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.